Stephen Resch

5.6k total citations · 1 hit paper
97 papers, 3.6k citations indexed

About

Stephen Resch is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Stephen Resch has authored 97 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 27 papers in Health and 22 papers in Epidemiology. Recurrent topics in Stephen Resch's work include Vaccine Coverage and Hesitancy (26 papers), HIV/AIDS Research and Interventions (18 papers) and Global Maternal and Child Health (18 papers). Stephen Resch is often cited by papers focused on Vaccine Coverage and Hesitancy (26 papers), HIV/AIDS Research and Interventions (18 papers) and Global Maternal and Child Health (18 papers). Stephen Resch collaborates with scholars based in United States, United Kingdom and Switzerland. Stephen Resch's co-authors include Zachary J. Ward, Steven L. Gortmaker, Michael W. Long, Angie L. Cradock, Catherine M. Giles, Angela Y. Chang, Thomas G. Weiser, Y. Claire Wang, Robert Hecht and Lisa A. Robinson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Stephen Resch

92 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simulation of Growth Trajectories of Childhood Obesity into Adulthood

2017 514 citations Stephen Resch et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Resch United States	32	1.2k	837	804	735	519	97	3.6k
Colin Sanderson United Kingdom	36	771 0.6×	805 1.0×	1.1k 1.4×	1.1k 1.5×	352 0.7×	95	5.3k
Gabriel Rada Chile	27	617 0.5×	592 0.7×	421 0.5×	907 1.2×	432 0.8×	169	3.7k
Maria Pia Fantini Italy	33	498 0.4×	499 0.6×	536 0.7×	741 1.0×	457 0.9×	195	4.0k
Lorna E. Thorpe United States	41	1.0k 0.9×	1.2k 1.5×	1.8k 2.2×	1.3k 1.7×	244 0.5×	221	5.9k
Francis Bajunirwe Uganda	30	936 0.8×	1.2k 1.4×	782 1.0×	1.0k 1.4×	733 1.4×	165	3.8k
Daniel J. Pallin United States	35	1.2k 1.0×	678 0.8×	603 0.8×	722 1.0×	483 0.9×	115	4.9k
Taryn Young South Africa	31	1.3k 1.1×	510 0.6×	568 0.7×	1.5k 2.1×	304 0.6×	163	4.2k
Max Bachmann United Kingdom	39	571 0.5×	1.1k 1.4×	1.1k 1.4×	1.5k 2.1×	662 1.3×	207	5.5k
Geert‐Jan Dinant Netherlands	45	1.0k 0.9×	394 0.5×	1.7k 2.1×	1.5k 2.1×	503 1.0×	224	6.4k
Warren J. McIsaac Canada	28	839 0.7×	585 0.7×	913 1.1×	775 1.1×	206 0.4×	60	3.2k

Countries citing papers authored by Stephen Resch

Since Specialization

Citations

This map shows the geographic impact of Stephen Resch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Resch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Resch more than expected).

Fields of papers citing papers by Stephen Resch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Resch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Resch. The network helps show where Stephen Resch may publish in the future.

Co-authorship network of co-authors of Stephen Resch

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Resch. A scholar is included among the top collaborators of Stephen Resch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Resch. Stephen Resch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hallett, Timothy B., Nicolas A. Menzies, Stephen Resch, et al.. (2025). The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study. The Lancet. 406(10500). 261–270.

Resch, Stephen, Ryoko Sato, Kevin Phelan, et al.. (2024). Cost-effectiveness of a simplified acute malnutrition program: a secondary analysis of the OptiMA randomized clinical trial in the Democratic Republic of the Congo. Health Policy and Planning. 40(3). 273–286.

Geng, Fangli, Brian E. McGarry, Meredith B. Rosenthal, et al.. (2024). Preferences for Postacute Care at Home vs Facilities. JAMA Health Forum. 5(4). e240678–e240678. 7 indexed citations

Clarke‐Deelder, Emma, Christian Suharlim, Susmita Chatterjee, et al.. (2024). Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush. Health Policy and Planning. 39(6). 583–592. 4 indexed citations

Levin, Ann, Logan Brenzel, Ulla Griffiths, et al.. (2022). WHO-led consensus statement on vaccine delivery costing: process, methods, and findings. BMC Medicine. 20(1). 88–88. 14 indexed citations

Feldhaus, Isabelle, Susmita Chatterjee, Emma Clarke‐Deelder, et al.. (2022). Examining decentralization and managerial decision making for child immunization program performance in India. Social Science & Medicine. 317. 115457–115457. 3 indexed citations

Clarke‐Deelder, Emma, Christian Suharlim, Susmita Chatterjee, et al.. (2021). Impact of campaign-style delivery of routine vaccines: a quasi-experimental evaluation using routine health services data in India. Health Policy and Planning. 36(4). 454–463. 16 indexed citations

Menzies, Nicolas A., Christian Suharlim, Stephen Resch, & Logan Brenzel. (2020). The efficiency of routine infant immunization services in six countries: a comparison of methods. Health Economics Review. 10(1). 1–1. 17 indexed citations

Kazemian, Pooyan, Anne M. Neilan, Stephen Resch, et al.. (2020). A novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease. Journal of Biomedical Informatics. 107. 103475–103475. 5 indexed citations

10.

Lee, David Jungpa, Nagalingeswaran Kumarasamy, Stephen Resch, et al.. (2019). Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector. PLoS ONE. 14(7). e0218890–e0218890. 48 indexed citations

11.

Feldhaus, Isabelle, Francis Dien Mwansa, Nicolas A. Menzies, et al.. (2019). Incorporating costing study results into district and service planning to enhance immunization programme performance: a Zambian case study. Health Policy and Planning. 34(5). 327–336. 5 indexed citations

12.

Lee, David Jungpa, Nagalingeswaran Kumarasamy, Stephen Resch, et al.. (2018). 2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector. Open Forum Infectious Diseases. 5(suppl_1). S582–S582. 1 indexed citations

13.

Resch, Stephen, et al.. (2018). Quantifying and reducing statistical uncertainty in sample-based health program costing studies in low- and middle-income countries. SAGE Open Medicine. 6. 2105837602–2105837602. 4 indexed citations

14.

Juneja, Sandeep, Aastha Gupta, Suerie Moon, & Stephen Resch. (2017). Projected Savings Through Public Health Voluntary Licences of HIV Drugs Negotiated By The Medicines Patent Pool (MPP). SSRN Electronic Journal. 1 indexed citations

15.

Jayaraman, Sudha, et al.. (2016). Cost-Effectiveness of a Model Infection Control Program for Preventing Multi-Drug-Resistant Organism Infections in Critically Ill Surgical Patients. Surgical Infections. 17(5). 589–595. 9 indexed citations

16.

Atun, Rifat, Angela Y. Chang, Osondu Ogbuoji, et al.. (2016). Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study. BMJ Open. 6(3). e009656–e009656. 35 indexed citations

17.

Jiang, Yushan, Stephen Resch, Xiaoxia Liu, et al.. (2015). The Cost of Responding to an Acinetobacter Outbreak in Critically Ill Surgical Patients. Surgical Infections. 17(1). 58–64. 10 indexed citations

18.

Hyle, Emily P., Ilesh Jani, Jonathan Lehe, et al.. (2014). The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis. PLoS Medicine. 11(9). e1001725–e1001725. 51 indexed citations

19.

Erim, Daniel, et al.. (2012). A Rapid Assessment of the Availability and Use of Obstetric Care in Nigerian Healthcare Facilities. PLoS ONE. 7(6). e39555–e39555. 26 indexed citations

20.

Kimmel, April D., Stephen Resch, Xavier Anglaret, et al.. (2012). Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability. Cost Effectiveness and Resource Allocation. 10(1). 12–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact